Autoimmune Neuropathy and CIDP

CIDP also known as chronic inflammatory demyelinating polyneuropathy is an auto-immune disease of the nervous system characterized by progressive weakness and impaired sensory function in the legs and arms. CIDP is closely related to Guillan-Barre Disease. Treatment for CIDP includes steroids and immunosuppressant drugs. Plasmapheresis (plasma exchange) and intravenous immunoglobulin (IVIG) therapy also commonly used. Aggressive treatment is used to prevent loss of axons. Some cases progress and are resistant to medical therapy, making it difficult to manage symptoms. There is hope that mesenchymal stem cells will mitigate some of the degenerative effects of CIDP neuropathy. Research is ongoing to evaluate the effects of stem cells on auto-immune conditions.

Autoimmune Neuropathy and CIDP with Chicago Stem Cell Treatment Center

CHICAGO STEM CELL TREATMENT CENTER AND CELL SURGICAL NETWORK has developed a specific SVF deployment protocol that attempts to utilize the potential immune-modulatory and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Schedule your Consultation with Dr. Ritacca Today

Do you have additional questions on how stem cells work and how they relate to your condition?  Contact us today to schedule your no-obligation consultation with Dr. Ritacca, Founder of the Chicago Stem Cell Treatment Center.  To get the process started, simply fill out our short CSCTC Confidential Candidate Application.  Once we receive your application, a stem cell coordinator will call you to schedule your phone or in person consultation with Dr. Ritacca. We look forward to educating you on the latest research for stem cell therapy.